ArticleBlood2018

LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML.

Monica Cusan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.